De Novo Anti-Type VII Collagen Antibodies in Patients with Recessive Dystrophic Epidermolysis Bullosa
Open Access
- 1 April 2014
- journal article
- Published by Elsevier in Journal of Investigative Dermatology
- Vol. 134 (4) , 1138-1140
Abstract
No abstract availableKeywords
Funding Information
- National Institutes of Health (RC4AR060535, RO1 AR33625, RO1 AR47981)
This publication has 15 references indexed in Scilit:
- Prevalence of specific anti-skin autoantibodies in a cohort of patients with inherited epidermolysis bullosaOrphanet Journal of Rare Diseases, 2013
- The COL7A1 mutation databaseHuman Mutation, 2011
- Bone Marrow Transplantation for Recessive Dystrophic Epidermolysis BullosaNew England Journal of Medicine, 2010
- Immune reactivity to type VII collagen: implications for gene therapy of recessive dystrophic epidermolysis bullosaGene Therapy, 2010
- Injection of Recombinant Human Type VII Collagen Corrects the Disease Phenotype in a Murine Model of Dystrophic Epidermolysis BullosaMolecular Therapy, 2009
- Potential of Fibroblast Cell Therapy for Recessive Dystrophic Epidermolysis BullosaJournal of Investigative Dermatology, 2008
- The classification of inherited epidermolysis bullosa (EB): Report of the Third International Consensus Meeting on Diagnosis and Classification of EBJournal of the American Academy of Dermatology, 2008
- Restoration of type VII collagen expression and function in dystrophic epidermolysis bullosaNature Genetics, 2002
- Ultraviolet A Irradiation Upregulates Type VII Collagen Expression in Human Dermal Fibroblasts.Journal of Investigative Dermatology, 1997
- Type VII Collagen, Anchoring Fibrils, and Epidermolysis BullosaJournal of Investigative Dermatology, 1993